Aberdeen Managed Distribution Fund Class A Accumulation
Sell : 108.82p | Buy : 108.82p | down 1.55p
Last valuation as at 08-01-2009
Asset allocation
Standard
|
|
Managed Funds |
47.97% |
|
|
UK Equities |
47.42% |
|
|
Cash |
1.86% |
|
|
Direct Property |
1.49% |
|
|
Investment Trusts |
0.65% |
|
|
UK Bonds |
0.60% |
|
|
Other |
0.02% |
X-ray
|
|
UK Equities |
47.55% |
|
|
UK Gilt |
30.04% |
|
|
International Bonds |
8.33% |
|
|
UK Bonds |
7.71% |
|
|
Cash |
2.42% |
|
|
Managed Funds |
2.06% |
|
|
Direct Property |
1.49% |
|
|
Investment Trusts |
0.65% |
|
|
Other |
-0.24% |
IMA sector allocation
|
|
Non-mutual |
50.17% |
|
|
UK Fixed Interest (offshore) |
45.91% |
|
|
Global Fixed Interest (offshore) |
2.06% |
|
|
Cash |
1.86% |
Standard top 10 holdings
|
Stock name |
% Weight |
Sector |
| 1 |
Aberdeen Global II Sterling Bond Fund Class Z |
20.40% |
Fixed Int-Sterling |
| 2 |
Aberdeen Global II Sterling Aggregate Bond Fund Class Z |
19.16% |
Fixed Int-Sterling |
| 3 |
Aberdeen Global II Long Dated Sterling Aggregate Bond Fund Class Z |
6.35% |
Fixed Int-Sterling |
| 4 |
Royal Dutch Shell B |
2.35% |
[N/A] |
| 5 |
British American Tobacco |
2.12% |
[N/A] |
| 6 |
Astrazeneca |
2.11% |
[N/A] |
| 7 |
BP |
2.10% |
[N/A] |
| 8 |
Vodafone Group |
2.10% |
[N/A] |
| 9 |
ABERDEEN GLOBAL EUROPEAN HIGH YIELD BD Z2 ACC |
2.06% |
Fixed Int-Europe |
| 10 |
National Grid |
2.00% |
[N/A] |
X-ray top 10 holdings
|
Stock name |
% Weight |
Country |
Sector |
| 1 |
4¼% Treasury Stock 2032 |
4.00% |
United Kingdom |
Bonds |
| 2 |
8% Treasury Stock 2021 |
3.91% |
United Kingdom |
Bonds |
| 3 |
6% Treasury Stock 2028 |
3.27% |
United Kingdom |
Bonds |
| 4 |
5% Treasury Gilt 2018 |
3.24% |
United Kingdom |
Bonds |
| 5 |
4¼% Treasury Gilt 2046 |
2.80% |
United Kingdom |
Bonds |
| 6 |
4¾% Treasury Stock 2020 |
2.66% |
United Kingdom |
Bonds |
| 7 |
4½% Treasury Gilt 2042 |
2.60% |
United Kingdom |
Bonds |
| 8 |
Royal Dutch Shell B |
2.35% |
United Kingdom |
Oil & Gas Producers |
| 9 |
British American Tobacco |
2.12% |
United Kingdom |
Tobacco |
| 10 |
Astrazeneca |
2.11% |
United Kingdom |
Pharmaceuticals & Biotechnology |
Where are the underlying funds invested?
|
UK Equities |
Int'l Equities |
UK Bonds |
Int'l Bonds |
UK Gilts |
Managed Funds |
Direct Property |
Other |
Cash and Equiv. |
Total |
| Basic Materials |
0.57% |
|
|
|
|
|
|
|
|
0.57% |
| Consumer Goods |
6.40% |
|
|
|
|
|
|
|
|
6.40% |
| Consumer Services |
9.50% |
|
|
|
|
|
|
|
|
9.50% |
| Financials |
10.37% |
|
|
|
|
|
1.49% |
0.65% |
|
12.51% |
| Health Care |
3.92% |
|
|
|
|
|
|
|
|
3.92% |
| Industrials |
2.76% |
|
|
|
|
|
|
|
|
2.76% |
| Oil & Gas |
6.36% |
|
|
|
|
|
|
|
|
6.36% |
| Technology |
|
|
|
|
|
|
|
|
|
|
| Telecommunications |
3.75% |
|
|
|
|
|
|
|
|
3.75% |
| Utilities |
3.51% |
|
|
|
|
|
|
|
|
3.51% |
| Direct Property |
|
|
|
|
|
|
|
|
|
|
| Cash and Equiv. |
|
|
|
|
|
|
|
|
2.42% |
2.42% |
| Managed Funds |
|
|
|
|
|
2.06% |
|
|
|
2.06% |
| Bonds |
|
|
7.71% |
8.33% |
30.04% |
|
|
|
|
46.09% |
| Non-Classified |
0.41% |
|
|
|
|
|
|
-0.24% |
|
0.17% |
| Total |
47.55% |
|
7.71% |
8.33% |
30.04% |
2.06% |
1.49% |
0.41% |
2.42% |
100.00% |
Data accurate as at 30/11/2008
Data provided by
